RIPK3 and temporal lobe epilepsy: KEY POINTS: In the early stage of experimental temporal lobe epilepsy with hippocampal sclerosis (TLE-HS), we observed activation of RIPK1, RIPK3 and MLKL in CA1 astrocytes, along with a reduction in astrocyte density, providing evidence for necroptotic cell death.